EU drug regulator finds possible link between AstraZeneca vaccine and rare blood clots

The European Medicines Agency says it has found a possible link between AstraZeneca’s COVID-19 vaccine and rare blood clotting issues in adults who had received the shot.



Click here to view the original article.